4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001561736-26-000002
Options or other derivatives
- Director acquired 52,796 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Clark Kenneth A · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +35,000 | 35,000 | D | ||
| 2026-01-02 | Grant or award : show line 2 in the form Stock Option (right to buy) | +17,796 | $8.76 | $155,893 | 17,796 | D |
Loading xslF345X05/wk-form4_1767742986.xml…